NPI: 1437526456 · SPOKANE VALLEY, WA 99216 · Federally Qualified Health Center (FQHC) · NPI assigned 08/25/2015
Authorized official WILSON, AARON controls 20+ related entities in our dataset. Read more
| Authorized Official | WILSON, AARON (CEO) |
| NPI Enumeration Date | 08/25/2015 |
Other providers sharing the same authorized official: WILSON, AARON
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,786 | $540K |
| 2019 | 12,378 | $485K |
| 2020 | 11,078 | $424K |
| 2021 | 14,593 | $475K |
| 2022 | 13,028 | $604K |
| 2023 | 13,753 | $617K |
| 2024 | 5,943 | $276K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49,811 | 48,775 | $2.37M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5,420 | 5,315 | $328K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,991 | 1,976 | $145K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,616 | 1,585 | $134K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,123 | 2,099 | $106K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4,735 | 4,484 | $100K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,598 | 1,575 | $72K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 1,703 | 1,522 | $48K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,185 | 1,162 | $38K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,952 | 2,924 | $38K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 555 | 549 | $18K |
| 81025 | 1,150 | 1,125 | $8K | |
| 81003 | 3,998 | 3,937 | $7K | |
| 87634 | 41 | 41 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 253 | 247 | $1K |
| 71046 | Radiologic examination, chest; 2 views | 87 | 87 | $1K |
| 90686 | 44 | 42 | $621.87 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 52 | 52 | $507.50 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 57 | 55 | $377.06 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 26 | 26 | $288.28 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 13 | 13 | $7.99 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 633 | 624 | $0.00 |
| 1035F | 561 | 555 | $0.00 | |
| 3008F | 8,148 | 7,069 | $0.00 | |
| 1034F | 807 | 783 | $0.00 |